Literature DB >> 26719542

HBXIP and LSD1 Scaffolded by lncRNA Hotair Mediate Transcriptional Activation by c-Myc.

Yinghui Li1, Zhen Wang1, Hui Shi1, Hang Li1, Leilei Li1, Runping Fang1, Xiaoli Cai1, Bowen Liu1, Xiaodong Zhang2, Lihong Ye3.   

Abstract

c-Myc is regarded as a transcription factor, but the basis for its function remains unclear. Here, we define a long noncoding RNA (lncRNA)/protein complex that mediates the transcriptional activation by c-Myc in breast cancer cells. Among 388 c-Myc target genes in human MCF-7 breast cancer cells, we found that their promoters could be occupied by the oncoprotein HBXIP. We confirmed that the HBXIP expression correlated with expression of the c-Myc target genes cyclin A, eIF4E, and LDHA. RNAi-mediated silencing of HBXIP abolished c-Myc-mediated upregulation of these target genes. Mechanistically, HBXIP interacted directly with c-Myc through the leucine zippers and recruited the lncRNA Hotair along with the histone demethylase LSD1, for which Hotair serves as a scaffold. Silencing of HBXIP, Hotair, or LSD1 was sufficient to block c-Myc-enhanced cancer cell growth in vitro and in vivo. Taken together, our results support a model in which the HBXIP/Hotair/LSD1 complex serves as a critical effector of c-Myc in activating transcription of its target genes, illuminating long-standing questions on how c-Myc drives carcinogenesis. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26719542     DOI: 10.1158/0008-5472.CAN-14-3607

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  53 in total

1.  Long non-coding RNA bladder cancer-associated transcript 2 contributes to disease progression, chemoresistance and poor survival of patients with colorectal cancer.

Authors:  Yongjun Ren; Caixia Zhao; Yi He; Hao Xu; Xuli Min
Journal:  Oncol Lett       Date:  2019-06-18       Impact factor: 2.967

2.  Mechanism of long noncoding RNAs as transcriptional regulators in cancer.

Authors:  Yan Huang; Qi Guo; Xi-Ping Ding; Xiangting Wang
Journal:  RNA Biol       Date:  2020-01-10       Impact factor: 4.652

3.  Hepatitis B X-interacting protein promotes the formation of the insulin gene-transcribing protein complex Pdx-1/Neurod1 in animal pancreatic β-cells.

Authors:  Hang Li; Zhen Wang; Yinghui Li; Runping Fang; Huawei Wang; Hui Shi; Xiaodong Zhang; Weiying Zhang; Lihong Ye
Journal:  J Biol Chem       Date:  2017-12-19       Impact factor: 5.157

4.  Oncoprotein HBXIP induces PKM2 via transcription factor E2F1 to promote cell proliferation in ER-positive breast cancer.

Authors:  Bo-Wen Liu; Tian-Jiao Wang; Lei-Lei Li; Lu Zhang; Yun-Xia Liu; Jin-Yan Feng; Yue Wu; Fei-Fei Xu; Quan-Sheng Zhang; Ming-Zhu Bao; Wei-Ying Zhang; Li-Hong Ye
Journal:  Acta Pharmacol Sin       Date:  2018-06-20       Impact factor: 6.150

5.  Long non-coding RNA IRAIN suppresses apoptosis and promotes proliferation by binding to LSD1 and EZH2 in pancreatic cancer.

Authors:  Yifan Lian; Juan Wang; Jing Feng; Jie Ding; Zhonghua Ma; Juan Li; Peng Peng; Wei De; Keming Wang
Journal:  Tumour Biol       Date:  2016-09-19

6.  The long non-coding RNA maternally expressed gene 3 activates p53 and is downregulated in esophageal squamous cell cancer.

Authors:  Desheng Lv; Run Sun; Qian Yu; Xuefei Zhang
Journal:  Tumour Biol       Date:  2016-10-24

Review 7.  The Role of Non-coding RNAs in Oncology.

Authors:  Frank J Slack; Arul M Chinnaiyan
Journal:  Cell       Date:  2019-11-14       Impact factor: 41.582

8.  lncRNA GCAWKR Promotes Gastric Cancer Development by Scaffolding the Chromatin Modification Factors WDR5 and KAT2A.

Authors:  Mingzhe Ma; Yan Zhang; Mingzhe Weng; Ye Hu; Yi Xuan; YiRen Hu; Kun Lv
Journal:  Mol Ther       Date:  2018-09-11       Impact factor: 11.454

Review 9.  Gene regulation of mammalian long non-coding RNA.

Authors:  Heeyoun Bunch
Journal:  Mol Genet Genomics       Date:  2017-09-11       Impact factor: 3.291

10.  LAMTOR5 raises abnormal initiation of O-glycosylation in breast cancer metastasis via modulating GALNT1 activity.

Authors:  Runping Fang; Feifei Xu; Hui Shi; Yue Wu; Can Cao; Hang Li; Kai Ye; Yingyi Zhang; Qian Liu; Shuqin Zhang; Weiying Zhang; Lihong Ye
Journal:  Oncogene       Date:  2019-12-13       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.